SCHEMBL5574170

SCHEMBL5574170

O=C(O)c1c(O)c2nccnc2n(Cc2ccccc2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.48
CNR1 P21554 1/20 0.48
FEN1 P39748 3/20 0.46
ERCC5 P28715 2/20 0.46
KDM4E B2RXH2 2/20 0.45
HIF1A Q16665 1/20 0.43
BCL2 P10415 1/20 0.42
MCL1 Q07820 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
EGLN1 Q9GZT9 2/20 0.41
LMNA P02545 4/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2088536 0.85 EGLN1 (0.62) CNR2CNR1EGLN1EGLN3
SCHEMBL2088737 0.85 KDM4E (0.52) CNR2CNR1KDM4ELMNAMEN1
SCHEMBL7837453 0.83 CNR2 (0.67) CNR2CNR1HIF1APDE4APDE4B
SCHEMBL27651859 0.75 CNR2 (0.55) CNR2CNR1PDE4APDE4BPDE4C
SCHEMBL7837905 0.75 CNR2 (0.58) CNR2CNR1KDM4EMEN1KMT2A
SCHEMBL7833529 0.75 EGLN1 (0.56) CNR2CNR1FEN1ERCC5KDM4E
SCHEMBL4167289 0.75 KDM4E (0.55) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL11488105 0.74 CNR1 (0.47) CNR2CNR1FEN1ERCC5KDM4E
SCHEMBL2087820 0.74 EGLN3 (0.59) EGLN1LMNAMEN1KMT2AEGLN3
SCHEMBL24002959 0.73 KDM4E (0.49) CNR2CNR1FEN1KDM4EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213335-A1 Prolyl Hydroxylase Inhibitors SMITHKLINE BEECHAM CORPORATION 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213335-A1 Prolyl Hydroxylase Inhibitors HIF1AN, EGLN2, EGLN3 CNR2 2524/4885CNR1 2493/4885FEN1 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.